Modulation of Plasma 25-Hydroxyvitamin D3 Level by Imatinib Mesylate in Patients with Chronic Myelogenous Leukemia: The Role of Uptake and Efflux Transporters. [PDF]
Curr Ther Res Clin Exp, 2022 Omran MM +5 more
europepmc +1 more source
Imatinib Mesylate-Loaded Rosin/Cinnamon Oil-Based In Situ Forming Gel against Colorectal Cancer Cells. [PDF]
Gels, 2022 Khaing EM +5 more
europepmc +1 more source
Медицинский вестник Юга России, 2010 Imatinib mesylate is a potent and high selective inhibitor of Bcr-Abl tyrosine kinase, which is established now as the standard of Philadelphia chromosome positive (Ph) chronic myeloid leukemia (CML) treatment.
S. I. Kutsev +8 more
doaj
Imatinib Mesylate Reduces Neurotrophic Factors and pERK and pAKT Expression in Urinary Bladder of Female Mice With Cyclophosphamide-Induced Cystitis. [PDF]
Front Syst Neurosci, 2022 Perkins M +4 more
europepmc +1 more source
Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHD. [PDF]
Cell Transplant, 2022 Baek DW +12 more
europepmc +1 more source
Dynein axonemal heavy chain 9 M4374I variation may have an effect on imatinib mesylate resistance in CML. [PDF]
Med Int (Lond), 2022 Yildirim MS +4 more
europepmc +1 more source
Cannabidiol modulates exosomal miRNA networks to enhance Imatinib mesylate response in chronic myelogenous leukemia. [PDF]
Glob Med GenetDonchev PP +3 more
europepmc +1 more source
Results of TETimaX Trial of Langerhans Cell Histiocytosis Treatment and Perspectives on the Role of Imatinib Mesylate in the Era of MAPK Signaling. [PDF]
Biomedicines, 2021 Montella L +7 more
europepmc +1 more source
Nail lichen planus associated with imatinib mesylate. [PDF]
JAAD Case RepAxler E +4 more
europepmc +1 more source
In vivo Pharmacokinetics and in vitro Release of Imatinib Mesylate-Loaded Liposomes for Pulmonary Delivery. [PDF]
Int J Nanomedicine, 2021 Xu H +5 more
europepmc +1 more source